Text Size

Pan-European survey of the topical ocular use of cyclosporine A [Utilisation de la cyclosporine A topique : une étude pan-européenne]

Labbé A., Baudouin C., Ismail D., Amrane M., Garrigue J.-S., Leonardi A., Figueiredo F.C., Van Setten G., Labetoulle M.

  • 2017
  • Journal Francais d'Ophtalmologie
View publication
  • Therapeutic Area

    Front of the eye (FOTE)

  • Categories

    Post-Approval studies/RWE

  • Affiliations

    Department of Ophthalmology, Quinze-Vingts National Ophthalmology Hospital, Paris, France; Ambroise Paré Hospital, AP–HP, University of Versailles Saint-Quentin-en-Yvelines, Versailles, France; Santen SAS, Evry, France; Department of Neuroscience, Ophthalmology Unit, University of Padua, Padua, Italy; Royal Victoria Infirmary, Newcastle University, Newcastle upon Tyne, United Kingdom; St. Eriks Eye Hospital, Karolinska Institute, Stockholm, Sweden; Ophthalmology Department, South Paris University, Bicêtre Hospital, AP–HP, Kermin-Bicêtre, France

Related Publications

Efficacy and Tolerance of Nova22007 Versus Vehicle in Patients With Vernal Keratoconjunctivitis (NOVATIVE): A Phase II/III, Multicenter, Double-masked, Randomized Study of 0.05% Cyclosporine A and 0.1% Ophthalmic Cationic Emulsion Versus Vehicle in Patients With Vernal Keratoconjunctivitis

Leonardi A, Pisella PJ, Benítez-Del-Castillo JM, Amrane M, Ismail D, Doan S, Bremond-Gignac D.

Correlation between gene expression and clinical scores in vernal keratoconjunctivitis

Leonardi A, Cavarzeran F, Rosani U, Righetti G, Garrigue JS, Brun P.

Topical cyclosporine A cationic ophthalmic emulsion in paediatric vernal keratoconjunctivitis: pooled analysis of randomised NOVATIVE and VEKTIS trials

Leonardi A, Doan S, Aragona P,  Amrane M, Ismail D, Montero J, Németh J, Bremond-Gignac D

Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022